Research

SPORTSWEAR REBUTTAL

Before we respond to some of the sell-side’s reactions to our Anta report, we need to warn you not to forward our research outside of your firm. It’s against our agreement with you, devalues our product and raises the chances of expensive legal and/or regulatory action against us. On to business… Much of Anta’s rebuttal came from selective disclosure to a group of analysts rather than anything published. Arguably, this is peddling potential insider information and stops us tackling their points head-on. Sell-side analysts have responded as expected. So far, of the reports we have seen, they have, in general, simply regurgitated…
Read more ›

Log In

Insights

A2 Milk

SELL: Ready to pop

Nigel Stevenson · 15 November 2018

WA2 Milk (A2M) has achieved super-normal profitability by selling a “special” kind of infant formula to Chinese consumers through unofficial distribution channels. The problem is that A2M has limited IP to protect its product, and competitors like Nestle are closing in. Meanwhile, new Chinese e-commerce rules may hamper its distribution network. It is difficult to see how A2M can protect its returns when it spends far less on marketing and research than peers. Consensus forecasts 30% compound revenue growth for two years on widening margins, placing it on 22x FY20 PER; we see slower revenue growth and contracting margins resulting…
Read more ›

CORPORATE TRAVEL

Short-seller claims lacks substance

Gillem Tulloch · 31 October 2018

We’re no fan of acquisition-driven business models, such as Corporate Travel (CTD), but they’re not a crime. The allegations presented thus far by hedge fund VGI Partners against CTD appear, in our opinion, to lack substance and in some instances are plain inflammatory. The short-seller alludes that CTD is faking its overseas profits but fails to provide hard evidence, or explain how this would impact CTD’s financials. In its defence, CTD has provided a fairly comprehensive rebuttal. This shorting campaign against CTD appears to be working as VGI has made allegations against an expensive stock, not because they have much…
Read more ›

SMOKE & MIRRORS

Embellishing performance using non-GAAP measures

Mark Webb · 24 October 2018

Accounting standards are designed to make life easy for investors. As such, companies moving away from GAAP measures should be regarded with suspicion. Our review of the 30 largest Chinese domiciled ADRs shows an increasing use of adjusted, vaguely defined and non-GAAP metrics which, in some cases, greatly exaggerates performance. This has likely led to inflated valuations and created a potential shorting opportunity as reality bites. The worst culprits are Bitauto, JD.com, Pinduoduo and Vipshop. GET PDF VIEW SLIDES Adjustments to GAAP data Of the 30 largest China-domiciled US-listed stocks, 26 publish adjusted net income (non-GAAP) alongside the GAAP figures…
Read more ›

Free Newsletter

GET OUR FREE NEWSLETTER

Input your email address below to sign-up to our free newsletter.